Trial Profile
This drug-drug interaction trial to investigate the pharmacokinetics and predict QTcF interval prolongation of naloxegol with ketoconazole in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Apr 2016
Price :
$35
*
At a glance
- Drugs Naloxegol (Primary) ; Ketoconazole
- Indications Constipation
- Focus Pharmacokinetics
- Acronyms TQT study
- Sponsors AstraZeneca
- 21 Apr 2016 New trial record
- 12 Mar 2016 Results of QT analysis (n=47) presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.